وثيقة

Metformin-induced lactic acidosis reported in the youngest pediatric patient with impaired renal function.

المعرف
DOI 10.5001/omj.2020.104
الناشر
Oman Medical Specialty Board.
ميلادي
2020-07
اللغة
الأنجليزية
الملخص الإنجليزي
Metformin is a widely used biguanide for the treatment of type 2 diabetes mellitus. Metformin-induced lactic acidosis (MALA) is a rare but potentially fatal entity in the pediatric age group, seen mainly in suicide attempts in adolescents. MALA has not yet been reported in younger patients or pediatric patients taking regular therapeutic doses. Here, we report a three-year-old female receiving therapeutic metformin who developed MALA. MALA should be suspected in patients with unexplained lactic acidosis and on regular metformin, especially in the setting of renal impairment or hypoxic events.
zcustom_txt_2
Al-Abdwaniyah, Raghad (2020). Metformin-induced lactic acidosis reported in the youngest pediatric patient with impaired renal function. Oman Medical Journal, 35 (4), e162 [1-4].
قالب العنصر
مقالات الدوريات

مواد أخرى لنفس الموضوع

مقالات الدوريات
0
0
Shaker, Mahmud.
Oman Medical Specialty Board.
2010-10